25-Hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment

Clinical Research in Cardiology

Volumn 102, Issue 4, 2013, Pages 299-304

  Ott, Christian ^a   Raff, Ulrike ^a   Schneider, Markus P ^a   Titze, Stephanie I ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Basal NO activity; Hypercholesterolemia; Renal vasculature; Statins

Indexed keywords

25 HYDROXYVITAMIN D; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; PLACEBO; ROSUVASTATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY DYSFUNCTION; MALE; METABOLIC PARAMETERS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

ADULT; AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PYRIMIDINES; REGRESSION ANALYSIS; SULFONAMIDES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84876487147     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-012-0534-1     Document Type: Article

References (34)

1. Dobnig H, Pilz S, Scharnagl H et al (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340-1349
2. Wang TJ, Pencina MJ, Booth SL et al (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503-511
3. Kendrick J, Targher G, Smits G et al (2009) 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third national health and nutrition examination survey. Atherosclerosis 205:255-260
4. Deanfield J, Donald A, Ferri C et al (2005) Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the European society of hypertension. J Hypertens 23:7-17
5. Sugden JA, Davies JI, Witham MD et al (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25:320-325
6. Tarcin O, Yavuz DG, Ozben B et al (2009) Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 94:4023-4030
7. Jablonski KL, Chonchol M, Pierce GL et al (2011) 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57:63-69
8. Mancia G, Laurent S, Agabiti-Rosei E et al (2009) Reappraisal of European guidelines on hypertension management: a European Society of hypertension task force document. J Hypertens 27:2121-2158
9. Wierema TK, Houben AJ, Kroon AA et al (2001) Nitric oxide dependence of renal blood flow in patients with renal artery stenosis. J Am Soc Nephrol 12:1836-1843
10. Jacobi J, Schneider MP, John S et al (2002) Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects. J Hypertens 20:525-530
11. Delles C, Jacobi J, John S et al (2002) Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension. Kidney Int 61:1462-1468
12. Schaufele TG, Schlaich MP, Delles C et al (2006) Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress. Kidney Int 70:1177-1181
13. (1998) Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 97:1440-1445
14. (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389
15. Sacks FM, Pasternak RC, Gibson CM et al (1994) Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard atherosclerosis reversibility project (HARP) group. Lancet 344:1182-1186
16. Shepherd J, Cobbe SM, Ford I et al (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333:1301-1307
17. Egashira K, Hirooka Y, Kai H et al (1994) Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89:2519-2524
18. John S, Schlaich M, Langenfeld M et al (1998) Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation 98:211-216
19. Perticone F, Ceravolo R, Maio R et al (2000) Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients. Atherosclerosis 152:511-518
20. Edwards CJ, Hart DJ, Spector TD (2000) Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355:2218-2219
21. Ott C, Schlaich MP, Schmidt BM et al (2008) Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia. Atherosclerosis 196:704-711
22. Cole BR, Giangiacomo J, Ingelfinger JR et al (1972) Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate. N Engl J Med 287:1109-1114
23. Schlaich MP, Jacobi J, John S et al (2000) Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature? Clin Sci (Lond) 99:293-302
24. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266-281
25. Looker AC, Dawson-Hughes B, Calvo MS et al (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771-777
26. Verbeke FH, Pannier B, Guerin AP et al (2011) Flow-mediated vasodilation in end-stage renal disease. Clin J Am Soc Nephrol 6:2009-2015
27. Al Mheid I, Patel R, Murrow J et al (2011) Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 58:186-192
28. Yavuz B, Ertugrul DT, Cil H et al (2009) Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther 23:295-299
29. Perez-Castrillon JL, Vega G, Abad L et al (2007) Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 99:903-905
30. Aloia JF, Li-Ng M, Pollack S (2007) Statins and vitamin D. Am J Cardiol 100:1329
31. London GM, Guerin AP, Verbeke FH et al (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613-620
32. Rezai MR, Wallace AM, Sattar N et al (2011) Ethnic differences in aortic pulse wave velocity occur in the descending aorta and may be related to vitamin D. Hypertension 58:247-253
33. Gupta A, Thompson PD (2011) The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis 215:23-29
34. Wu-Wong JR, Nakane M, Ma J et al (2007) Statins do not directly activate vitamin D receptor. J Thromb Haemost 5:415-416